Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study

Gemelli M.

;Sala L.;Morabito A.;Sforza V.;Cortellini A.;La Cava G.;Bertolini F.;Guaitoli G.;Carnio S.;Novello S.;Leonetti A.;Tiseo M.;Mazzoni F.;Cosso F.;Macerelli M.;Membrino A.;Metro G.;Chiari R.;Genova C.;Berardi R.;Tassistro E.;Antolini L.;Cortinovis D. L.

2026-01-01